1. Home
  2. ITRM vs CPHI Comparison

ITRM vs CPHI Comparison

Compare ITRM & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.56

Market Cap

26.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITRM
CPHI
Founded
2015
N/A
Country
Ireland
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
26.3M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
ITRM
CPHI
Price
$0.03
$0.56
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
30.9M
9.0K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
57.43
N/A
EPS
N/A
N/A
Revenue
N/A
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
$947.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.50
52 Week High
$1.16
$2.60

Technical Indicators

Market Signals
Indicator
ITRM
CPHI
Relative Strength Index (RSI) 26.10 36.38
Support Level N/A $0.53
Resistance Level $0.39 $0.66
Average True Range (ATR) 0.02 0.04
MACD -0.01 -0.01
Stochastic Oscillator 3.34 13.99

Price Performance

Historical Comparison
ITRM
CPHI

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: